Catamenial migraine: epidemiology, pathogenesis, diagnosis, clinical features
https://doi.org/10.14412/2074-2711-2010-78
Abstract
Based on a review of the literature, the authors consider the pathogenesis, diagnosis, epidemiology, and clinical features of catamenial migraine. The view that catamenial migraine attacks are severest receives more and more support. The criteria that may be used to predict a severer course of catamenial migraine attacks in a specific patient are to be further defined.
About the Authors
S. A. Gromova
I.M. Sechenov Moscow Medical Academy
Russian Federation
Russian Federation
G. R. Tabeeva
I.M. Sechenov Moscow Medical Academy
Russian Federation
Russian Federation
References
1. <div><p>Lipton R.B., Stewart W.F., Diamond S. et al. Prevalence and burden of migraine in the United States: Data from the American Migraine Study II. Headache 2001; 41: 646-57.</p><p>Stewart W.F., Lipton R.B., Chee E. et al. Menstrual cycle and headache in a population sample of migraineurs. Neurology 2000; 55(10): 1517-23.</p><p>Launer L.J., Terwindt G.M., Ferrari M.D. The prevalence and characteristics of migraine in a population-based cohort: the GEM study. Neurology 1999; 53(3): 537-42.</p><p>Lipton R.B., Bigal M.E., Diamond M. et al. Migraine prevalence, disease burden, and the need for preventive therapy. Neurology 2007; 68(5): 343-9.</p><p>Hutchinson S., Peterlin B.L., Portenoy R.K. Menstrual migraine. Oxford: University Press, 2008.</p><p>Martin V.T., Lipton R.B. Epidemiology and biology of menstrual migraine. Headache 2008; 48: S124-S130.</p><p>Баранаева Н.Ю. Нормальный менструальный цикл и его нарушения. Consilium medicum 2002; 2(3).</p><p>www.yogin.ru/parser.php?p_id=22&r_id= 89&c_id=101&an_cur_part=1&a_id=628&vie w_msg=1</p><p>Зенина Н.В. Состояние церебральной вегетативной регуляции в межприступном периоде катамениальной мигрени. В кн.: Болезни и дисфункции нервной системы у женщин репродуктивного возраста. Сб. научных трудов. Под ред. А.С. Деева. Рязань: Изд-во РГМУ, 1995.</p><p>Somerwille B.W. The role of estradiol withdrawal in the etiology of menstrual migraine. Neurology 1972; 22: 355-65.</p><p>Gauthier J.G., Fournier A.L., Roberge C. The differential effects of biofeedback in the treatment of menstrual and nonmenstrual migraine. Headache 1991; 31: 82-90.</p><p>Martin V.T., Behbehani М. Ovarian hormones and migraine headache: understanding mechanisms and pathogenesis. Part I. Headache 2006; 46: 3-23.</p><p>Martin V.T., Behbehani М. Ovarian hormones and migraine headache: understanding mechanisms and pathogenesis. Part II. Headache 2006; 46: 365-86.</p><p>Newman L.C. Understanding the causes and prevention of menstrual migraine: the role of estrogen. Headache 2007; 47(Suppl. 2): S86-S94.</p><p>Brandes J.L. The influence of estrogen on migraine. JAMA 2006; 295: 1824-30.</p><p>Martin V.T., Lee J., Behbehani M.M. Sensitization of the trigeminal sensory system during different stages of the rat estrous cycle: implications for menstrual migraine. Headache 2007; 47: 552-63.</p><p>MacGregor E.A. «Menstrual» migraine: towards a definition. Cephalalgia 1996; 16: 11-21.</p><p>MacGregor E.A., Hackshaw A. Prevalence of migraine on each day of the natural menstrual cycle. Neurology 2004; 63(2): 351-3.</p><p>Herzog A.G. Neuroactive properties of reproductive steroids. Headache 2007; 47(Suppl. 2): S68-S78.</p><p>Brun J., Claustrat B., Saddier P., Chazot G. Nocturnal melatonin excretion is decreased in patients with migraine without aura attacks associated with menses. Cephalalgia 1995; 15: 136-9; discussion 179.</p><p>Facchinetti F., Martignoni E., Fioroni L. et al. Opioid control of the hypothalamuspituitary-adrenal axis cyclically fails in menstrual migraine. Cephalalgia 1990; 10: 51-6.</p><p>Guidotti M., Mauri M., Barak C. et al. Frovatriptan vs. transdermal oestrogens or naproxen sodium for the prophylaxis of menstrual migraine. J Headache Pain 2007; 8(5): 283-8.</p><p>Mauskop A., Altura B.T., Altura B.M. Serum ionized magnesium levels and serum ionized calcium/ionized magnesium ratios in women with menstrual migraine. Headache 2002; 42: 242-8.</p><p>Okamoto K., Hirata H., Takeshita S., Bereiter D.A. Response properties of TMJ units in superficial laminae at the spinomedullary junction of female rats vary over the estrous cycle. J Neurophysiol 2003; 89: 1467-77.</p><p>Peres M.F., Zukerman E., da Cunha Tanuri F. et al. Melatonin, 3 mg, is effective for migraine prevention. Neurology 2004; 63: 757.</p><p>Srikiatkhachorn A., Suwattanasophon C., Ruangpattanatawee U., Phansuwan-Pujito P.; 2002 Wolff Award. 5-HT2A receptor activation and nitric oxide synthesis: A possible mechanism determining migraine attacks. Headache 2002; 42: 566-74.</p><p>Vogler B., Rapoport A.M., Tepper S.J. et al. Role of melatonin in the pathophysiology of migraine: Implications for treatment. CNS Drugs 2006; 20: 343-50.</p><p>Granella F., Sances G., Allais G. et al. Characteristics of menstrual and nonmenstrual attacks in women with menstrually related migraine referred to headache centers. Cephalalgia 2004; 24: 707-16.</p><p>Dzoljic E., Sipetic S., Vlajinac H. et al. prevalence of menstrually related migraine and nonmigraine primary headache in female students of Belgrade university. Headache 2002; 42: 185-93.</p><p>Diamond M.L., Cady R.K., Mao L. et al. Characteristics of migraine attacks and responses to almotriptan treatment: a comparison of menstrually related and nonmenstrually related migraines. Headache 2008; 48(2): 248-58.</p><p>Табеева Г.Р. Менструальная мигрень. РМЖ 2008; 16(4): 195-9.</p><p>Headache Classification Committee of the International Society (2004). The International Classification of Headache Disorders. Cephalalgia 2004; 24 (Suppl. 1): 1-160.</p><p>Couturier E.G.M., Bomhof M.A.M., Knuistingh Neven A., van Duijn N.P. Menstrual migraine in a representative Dutch population sample: prevalence, disability and treatment. Cephalalgia 2003; 23: 302-8.</p><p>MacGregor A. (ed.). Migraine in women. L.: Martin Dunitz, 1999.</p><p>Gross M.L.P., Barrie M., Bates D. et al. The efficacy of sumatriptan in menstrual migraine. Eur J Neurol 1995; 2: 144-5.</p><p>MacGregor A. Migraine associated with menstruation. Funct Neurol 2000; 15 (Suppl.): 143-53.</p><p>Silberstein S.D., Merriam G.R. Estrogens, progestins, and headache. Neurology 1991; 41: 786-93.</p><p>Solbach P., Sargent J., Coyne L. Menstrual migraine headache: results of a controlled, experimental, outcome study of non-drug treatments. Headache 1984; 24: 75-8.</p><p>Allais G., Acuto G., Cabarrocas X. et al. Efficacy and tolerability of almotriptan versus zolmitriptan for the acute treatment of menstrual migraine. Neurol Sci 2006; 27(Suppl. 2): S193-S197.</p><p>Goadsby P.J., Massiou H., Pascual J. et al. Almotriptan and zolmitriptan in the acute treatment of migraine. Acta Neurol Scand 2007; 115: 34-40.</p><p>Silberstein S.D., Massiou H., Le Jeunne C. et al. Rizatriptan in the treatment of menstrual migraine. Obstet Gynecol 2000; 96: 237-42.</p><p>Macgregor E.A., Victor T.W., Hu X. et al. Characteristics of menstrual vs nonmenstrual migraine: a post hoc, within-woman analysis of the usual-care phase of a nonrandomized menstrual migraine clinical trial. Headache 2010; 50: 528-38.</p><p>Pringsheim T., Davenport W.J., Dodick D. Acute treatment and prevention of menstrually related migraine headache: evidence-based review. Neurology 2008; 70(17): 1555-63.</p><p>Dowson A.J., Kilminster S.G., Salt R. et al. Disability associated with headaches occurring inside and outside the menstrual period in those with migraine: a general practice study. Headache 2005; 45: 274-82.</p><p>Visser J., Vriend F. Risk factors for headache recurrence after sumatriptan: a study in 366 migraine patients. Cephalalgia 1996; 16: 264-9.</p></div><br />
Review
For citations:
Gromova SA, Tabeeva GR. Catamenial migraine: epidemiology, pathogenesis, diagnosis, clinical features. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2010;2(2):11-19. (In Russ.) https://doi.org/10.14412/2074-2711-2010-78
Views: 1424
Email this article 